» Articles » PMID: 35984551

HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?

Overview
Publisher Current Science
Date 2022 Aug 19
PMID 35984551
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Multiple tools exist to support the primary prevention of HIV in pregnant and postpartum women; however, there are opportunities to enhance their use and impact. This review summarizes the current status of HIV prevention tools and existing gaps and opportunities to improve their use along the pregnancy care continuum.

Recent Findings: HIV screening efforts have steadily improved with close to universal screening of pregnant women in several East and Southern African countries. Strategies to implement partner testing through the distribution of HIV self-test kits are promising though linkage to care remains challenging. Syphilis screening rates are increasing though detection of other sexually transmitted infections could benefit from improved diagnostic capacity. Male and female condoms are rarely used and are often not the optimal tool of choice during pregnancy. Oral pre-exposure prophylaxis (PrEP) is a promising tool, although barriers such as the need for daily adherence, side effects, and stigma may limit its use. There is a growing pipeline of PrEP agents with alternative delivery platforms that might suit women's preferences better and supports the notion that choice is vital to improving HIV prevention coverage during the pregnancy-postpartum continuum. Clear guidance on which tools to use and how to use them, safety data supporting their use, and surveillance data documenting the scale and effectiveness of the tools will be imperative in establishing a path to more impactful prevention efforts among pregnant and postpartum women.

Citing Articles

Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.

Mugambi M, Odhiambo B, Dollah A, Marwa M, Nyakina J, Kinuthia J J Int AIDS Soc. 2024; 27 Suppl 1:e26301.

PMID: 38965978 PMC: 11224584. DOI: 10.1002/jia2.26301.


Systematic review and meta-analysis of seroprevalence of human immunodeficiency virus serological markers among pregnant women in Africa, 1984-2020.

Ebogo-Belobo J, Kenmoe S, Andre Mbongue Mikangue C, Tchatchouang S, Robertine L, Takuissu G World J Crit Care Med. 2024; 12(5):264-285.

PMID: 38188451 PMC: 10768416. DOI: 10.5492/wjccm.v12.i5.264.

References
1.
Peters A, Jansen W, van Driel F . The female condom: the international denial of a strong potential. Reprod Health Matters. 2010; 18(35):119-28. DOI: 10.1016/S0968-8080(10)35499-1. View

2.
Moreno R, Nababan H, Ota E, Wariki W, Ezoe S, Gilmour S . Structural and community-level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections. Cochrane Database Syst Rev. 2014; (7):CD003363. PMC: 11184921. DOI: 10.1002/14651858.CD003363.pub3. View

3.
Wynn A, Moucheraud C, Martin N, Morroni C, Ramogola-Masire D, Klausner J . Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana. Sex Transm Dis. 2021; 49(1):59-66. PMC: 8663512. DOI: 10.1097/OLQ.0000000000001517. View

4.
Worku M, Teshale A, Tesema G . Prevalence and Associated Factors of HIV Testing Among Pregnant Women: A Multilevel Analysis Using the Recent Demographic and Health Survey Data from 11 East African Countries. HIV AIDS (Auckl). 2021; 13:181-189. PMC: 7886292. DOI: 10.2147/HIV.S297235. View

5.
Hershow R, Zimba C, Mweemba O, Chibwe K, Phanga T, Dunda W . Perspectives on HIV partner notification, partner HIV self-testing and partner home-based HIV testing by pregnant and postpartum women in antenatal settings: a qualitative analysis in Malawi and Zambia. J Int AIDS Soc. 2019; 22 Suppl 3:e25293. PMC: 6639664. DOI: 10.1002/jia2.25293. View